Hologic Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company was founded in 1985 and is based in Bedford, Massachusetts.
HOLX Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Hologic Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Hologic Inc ranked in the 34th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 44%. As for the metrics that stood out in our discounted cash flow analysis of Hologic Inc, consider:
HOLX's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 26.29% of tickers in our DCF set.
Hologic Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
The weighted average cost of capital for the company is 8. This value is greater than just 20.97% stocks in the Healthcare sector that generate free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
CMD, DYNT, MD, RSCF, and GSK can be thought of as valuation peers to HOLX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
C-Arms Market research report gives details of recent developments, product launches, joint ventures, mergers, acquisitions, and competitive research by the several key players and brands that are driving the market. While forming this top-class market report containing detailed market analysis, inputs
The market report study titled ‘Global Hysteroscope Market Report’ published by Reports and Data offers in-depth and comprehensive research describing the scope of the market and market insights until 2027. The report will include details about potential opportunities, new projects,
Trichomonas Rapid Testing Market 2020 Global Industry research report studies latest Trichomonas Rapid Testing industry aspects market size, share, trends, growth, business overview and Trichomonas Rapid Testing industry scenario during the forecast period (2020-2025). Global Trichomonas Rapid Testing Market overview: Trichomonas rapid
DBMR has added a new report titled Mobile C-Arm Equipment Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The data and the information regarding the industry are taken from
According to the new market research report "Anatomic Pathology Market by Product & Service [Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology], Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)], End User, Region - Global Forecasts to 2025", published by MarketsandMarkets™, analyzes and